Esophageal retention is typically evaluated by timed-barium esophagram in patients treated for achalasia. Esophageal bolus clearance can also be evaluated using high-resolution impedance manometry. We evaluated the associations of conventional and novel high-resolution impedance manometry metrics, esophagram, and patient-reported outcomes (PROs) in achalasia.
A chalasia is the prototypical esophageal motor disorder and is characterized by impaired deglutitive lower esophageal sphincter relaxation and absent peristalsis. 1, 2 Bolus clearance is the fundamental function of the esophagus, which when disrupted by the motility abnormalities of achalasia results in esophageal retention and symptoms of esophageal dysphagia, chest pain, and regurgitation. Symptomatic improvement is an essential objective and often the primary outcome measure for gauging treatment response in achalasia. Nevertheless, discordance often is observed between patient symptoms and objective radiographic and manometric measures of esophageal function. [3] [4] [5] Esophageal retention, as measured by timed-barium esophagram (TBE), was shown to be more predictive of treatment failure in achalasia than symptom severity. 3 Therefore, in patients with previously treated achalasia, it is recommended that follow-up evaluations involve intermittent objective assessments, including TBE and/or manometry.
Esophageal manometry is considered the primary method to assess esophageal motility and, when combined with multichannel intraluminal esophageal impedance sensors, the esophageal function evaluation can be enhanced by assessing the interplay between esophageal motility and bolus transit. 6, 7 Use of esophageal impedance-manometry, however, was limited by its dichotomous qualitative evaluation of bolus clearance as complete or incomplete. 6, 7 Advances in highresolution impedance manometry (HRIM) offer an improved quantitative evaluation using a novel HRIM measure, the esophageal impedance integral (EII) ratio. 8 By using high-resolution impedance topography plots (Z-plots), the proportion of retained bolus can be quantified to better characterize esophageal bolus clearance.
We recently reported that the EII ratio outperformed other impedance-manometry metrics in correlating with symptoms among patients with dysphagia, but without a major esophageal motility disorder. 9 Given the benefits of assessing achalasia outcomes with TBE, we hypothesized that assessing achalasia patients during follow-up evaluation after treatment with the EII ratio would benefit the outcome evaluation. Thus, we aimed to evaluate the value of TBE, via barium column height, and HRIM, via the traditional dichotomized bolus transit, and the novel EII ratio, in assessing patient-reported outcome (PRO) in patients with achalasia after intervention.
Methods

Subjects
Patients with achalasia and previous treatment with pneumatic dilation, laparoscopic Heller's myotomy (often with Dor or Toupet fundoplasty), and/or per-oral endoscopic myotomy returning for follow-up evaluation or referred from elsewhere were prospectively recruited and evaluated. Seventy consecutive patients (without hiatal hernia > 2 cm) evaluated between April 2013 and December 2015 who completed HRIM, symptom questionnaires, and TBE were included in the analysis; these patients have been described previously, although 5 patients from that report were excluded from this analysis because of technical issues with impedance sensors that prevented reliable analysis of HRIM measures of esophageal retention. 10 The time interval between evaluation and the most recent pneumatic dilation or myotomy was noted. When available, HRM performed before intervention was evaluated according to the Chicago Classification to provide an achalasia subtype. 1 When pretreatment manometry was not available, the diagnosis of achalasia was assumed based on reported manometry findings and subsequent treatment. The study protocol was approved by the Northwestern University Institutional Review Board.
Symptom Assessment
Symptoms were assessed by patient completion of written questionnaires at the time of HRIM. Questionnaires included the Eckardt score and the brief esophageal dysphagia questionnaire (BEDQ). 11 The Eckardt score (range, 0-12) was generated by the sum of scores for dysphagia, chest pain, and regurgitation based on the frequency of each symptom (0, never; 1, occasional; 2, daily; 3, with each meal) plus a score based on the degree of weight loss since the last therapeutic intervention (0, none; 1, <10 lbs; 2, 10-20 lbs; 3, >20 lbs). Patients reporting an Eckardt score 3 were considered a good PRO; those with Eckardt score > 3 were considered a poor PRO.
The BEDQ is a validated questionnaire that consists of eight 6-point Likert scale questions (scored, 0-5) that assess the frequency and severity of dysphagia and odynophagia and 2 open-ended questions regarding frequency of food impactions and related emergency room visits. 12 Scores range from 0 (asymptomatic) to 50; a BEDQ score threshold of 10 was reported previously as an optimal score to diagnose major esophageal motor dysfunction and thus a BEDQ < 10 was considered a good PRO; a BEDQ ! 10 was considered a poor PRO.
Timed-Barium Esophagram Protocol and Analysis
Timed-barium esophagrams were performed in the upright position with radiograph images of the esophagus obtained at 1, 2, and 5 minutes after ingestion of 200 mL of low-density (45% weight-to-volume) barium sulfate. The height of the barium column (in centimeters) at 5 minutes was measured vertically from the esophagogastric junction (EGJ).
High-Resolution Impedance Manometry Protocol and Analysis
After a minimum 6-hour fast, HRIM studies were completed using a 4.2-mm outer-diameter, solid-state assembly with 36 circumferential pressure sensors at 1-cm intervals and 18 impedance segments at 2-cm intervals placed transnasal to span from the hypopharynx to stomach (Medtronic, Inc, Shoreview, MN). After a 2-minute baseline recording, the HRIM protocol using a 0.45% saline solution included 10 swallows (5 mL) in a supine position and 5 swallows (5 mL) in the upright position.
Manometry studies were analyzed using ManoView version 3.0 analysis software (Medtronic, Inc) according to the Chicago Classification. 1, 13 Esophageal motility diagnoses were designated from the supine swallows in accordance with the Chicago Classification v3.0, using a median integrated relaxation pressure of more than 15 mm Hg as the upper limit of normal. 1 Although the Chicago Classification was designed and intended for patients without previous surgery, we used the classification scheme in our posttreatment cohort to describe the motility patterns observed on follow-up evaluation. Based on our previous findings that assessing upright liquid swallows provided better symptom association compared with supine swallows, we used the 5 upright swallows for further testing. 9 The HRIM plots of upright liquid swallows were analyzed with placement of impedance channels 5, 10, 15, and 20-cm proximal to the EGJ to emulate a previous method to characterize dichotomized bolus clearance. 6, 7 Dichotomized bolus clearance was assessed by an investigator (D.A.C.) blinded to other clinical details. Complete bolus clearance was considered if bolus entry (ie, 50% decrease in impedance from baseline to nadir) occurred at the 20-cm channel, and bolus exit (ie, return to 50% impedance point) occurred at the 15-cm, 10-cm, and 5-cm channels. Incomplete bolus clearance was considered if bolus exit was not identified at any of the 3 distal impedance measurement sites. Based on previously used thresholds, 6, 7 normal bolus transit was defined as complete bolus clearance in more than 70% of swallows, abnormal bolus transit was defined as complete bolus clearance in 30% of swallows.
To calculate the EII ratio, HRIM data of the upright 5-mL swallows for each subject were exported to MATLAB (The MathWorks, Inc, Natick, MA) into a customized program. The EII ratio was calculated as previously described by an investigator (Z.L.) who was blinded to other clinical details. 8, 9 The measurement region of interest including the swallow to the completion of peristalsis (or 12 seconds if peristalsis was absent) was divided into 2 impedance domains: swallow (Z1) and postswallow (Z2) (Figure 1 ). The amount of bolus present within each domain was quantified by measuring the impedance-pixel density (impedance value Â time Â axial length), that is, the EII. Finally, the EII ratio was calculated as the ratio of residual bolus volume (EII-Z2) relative to the intra-esophageal bolus volume immediately after the swallow, but before the deglutitive contraction (EII-Z1): EII ratio ¼ (EII-Z2) / (EII-Z1). A greater EII ratio indicated a greater degree of bolus retention. 8 Excellent inter-rater agreement (intraclass correlation coefficient, 0.905; 95% CI, 0.875-0.928) of the EII ratio calculation was shown recently between 2 raters analyzing 200 swallows from patients with and without achalasia. 14 
Statistical Analysis
Descriptive statistics for all continuous and ordinal measures were presented as median and interquartile range (IQR), unless otherwise stated. Correlations were assessed using the Spearman rho. Outcome groups were compared using the Mann-Whitney U test for continuous variables and the chi-squared test for dichotomous and categoric variables. Receiver operating characteristic curves were generated by plotting the sensitivity by false-positive rate (1 -specificity) to predict good PRO for incremental value increases of each HRIM and TBE metric. The optimal threshold value for each metric was chosen as the closest value to 100% sensitivity and 0% false-positive rate (the 0, 1 point on the graph). Analyses assumed a 5% level of statistical significance.
Results
Study Subjects
Seventy patients with achalasia, with a mean age of 51 years (range, 20-81 y; 30 (43%) women) were included ( Table 1 ). The median follow-up interval was 12 months (range, 3-183 mo) after a previous intervention with pneumatic dilation (n ¼ 10; 14%), laparoscopic Heller's myotomy (n ¼ 25; 36%), or per-oral endoscopic myotomy (n ¼ 35; 50%); 2 patients had received an esophageal botulinum toxin injection since a previous intervention that occurred 6 months and 2 years before follow-up testing. Nine patients had received more than 1 previous intervention. The majority of patients (58; 83%) were treated at Northwestern, the remaining 12 (17%) patients received their previous intervention at an external facility (2 with pneumatic dilation, 10 with laparoscopic Heller's myotomy).
Among all patients, the median Eckardt score was 2 (IQR, 1-4). Forty-six (66%) patients had a good PRO and 24 (34%) had a poor PRO. Two patients did not complete the BEDQ. Among the remaining 68 patients, the median BEDQ was 5 (IQR, 1-11). By the BEDQ, 45 (66%) patients had a good PRO and 23 (34%) had a poor PRO. The percentage agreement on PRO between the ES and BEDQ was 87% (k ¼ 0.701). Characteristics by PRO are shown in Table 1 .
Measures of Esophageal Clearance
Among all patients, the median TBE column height was 3.2 cm (IQR, 0-7.2 cm), and the EII ratio was 0.36 (IQR, 0.24-0.5). The correlation between the TBE column height and the EII ratio was 0.20.
Nineteen patients (27%) had complete bolus transit and the remaining 51 (73%) had incomplete bolus transit. TBE column height was 0 cm (0-2.3 cm) among patients with complete bolus transit and 4 cm (1-10 cm) among patients with incomplete bolus transit (P < .001). The EII ratio was 0.28 (0.18-0.35) among patients with complete bolus transit and 0.39 (0.25-0.55) among patients with incomplete bolus transit (P ¼ .002).
Relationships with HRIM parameters and TBE column height, EII ratio, and bolus transit are presented in Supplementary Table 1 .
Associations of Esophageal Clearance Metrics With Patient-Reported Outcome
The correlation between the Eckardt score and TBE column height was 0.437 and between the Eckardt score and EII ratio was 0.496. The correlation between the BEDQ score and TBE column height was 0.304 and between the BEDQ score and EII ratio was 0.366 (all statistically significant). PRO groups differed in TBE column height (Eckardt score, P < .001; BEDQ, P ¼ .042) and EII ratio (Eckardt score, P < .001; BEDQ, P ¼ .02), as shown in Figure 2 , with greater column height and greater EII ratio associated with poor PRO. Of the 19 patients with complete bolus transit, 13 (68%) had a good PRO (defined both by Eckardt score and BEDQ) whereas 33 of 51 (65%) and 32 of 49 (65%) patients with incomplete bolus transit also had a good PRO, as defined by Eckardt score and BEDQ, respectively (P ¼ .999 for both PROs) (Figure 2) . The diagonal dashed line represents the (A) expected or (B) actual peristaltic wave. After accounting for the baseline impedance, the areas of bolus presence were determined (enclosed within the white lines) and the bolus volumes within each domain were measured from the impedance pixel density within areas of bolus presence. The swallows shown yielded EII ratios of (A) 0.28 and (B) 0.33. Reproduced with permission from the Esophageal Center at Northwestern.
Receiver operating characteristic curves (Figure 3 ) of metrics related to good PRO defined by Eckardt score yielded areas under the curve of 0.752 (95% CI, 0.631-0.873) for TBE column height and 0.789 (95% CI, 0.666-0.911) for the EII ratio. Receiver operating characteristic curves of metrics related to a good PRO defined by BEDQ yielded areas under the curve of 0.648 (95% CI, 0.504-0.792) for TBE column height and 0.731 (95% CI, 0.585-0.878) for EII ratio. The use of 5 cm as the cut-off point for TBE column height yielded a sensitivity of 78% (Eckardt score) and 76% (BEDQ), and a specificity of 54% (Eckardt score) and 43% (BEDQ) to detect a good PRO. 4, 5 Achieving complete esophageal emptying at 5 minutes (TBE column height of 0 cm) yielded a sensitivity of 46% (Eckardt score) and 40% (BEDQ), and a specificity of 88% (Eckardt score) and 74% (BEDQ) to detect good PRO. 15 The ideal cut-off points to identify a good PRO identified via the receiver operating characteristic curves was 3 cm for TBE column height and 0.41 for the EII ratio; associated sensitivities and specificities to predict good PROs are shown in Table 2 .
Combined Use of Timed-Barium Esophagram and High-Resolution Impedance Manometry Metrics to Predict Patient-Reported Outcome
Plotting the TBE column height with the EII ratio or bolus transit showed the effects of complementary use of TBE with HRIM evaluation to detect PRO. When determining PRO by the Eckardt score (Figure 4) , 23 of 25 (92%) patients with both a favorable TBE column height and favorable EII ratio had a good PRO, whereas 14 of 17 (82%) patients with a poor TBE column height and poor EII ratio had a poor PRO. Twenty of 28 (71%) patients with a mixed TBE-EII ratio results (ie, favorable TBE, poor EII ratio, or vice versa) had a good PRO. In terms of dichotomous bolus transit, 12 of 16 (75%) patients with a favorable TBE column height and complete bolus transit had a good PRO, whereas 16 of 32 patients (50%) with poor TBE and incomplete bolus transit had a poor PRO. Eighteen of 22 (82%) patients with mixed TBE bolus transit results had a good PRO, although 17 of these 18 patients (94%) had a favorable TBE column height with incomplete bolus transit. Similar results were observed when the BEDQ was used to determine PRO (not shown).
Discussion
We evaluated the relationships of PROs (Eckardt score and BEDQ) with radiographic (TBE) and HRIM measures of esophageal retention among achalasia patients during follow-up evaluation after pneumatic dilation or myotomy and found that the novel HRIM metric, the EII ratio, carried a similar to enhanced association with PRO as TBE column height. Furthermore, (23) 2 (4) 14 (58) 2 (4) 12 (52) Motility diagnosis at follow-up evaluation, c n (%) a,b
Type I achalasia 9 (13) 5 (11) 4 (17) 4 (9) 4 (17) Type II achalasia 5 (7) 1 (2) 4 (17) 1 (2) complementary use of TBE column height and the EII ratio led to an improvement in PRO association. Previous work has shown the benefit for quantifying esophageal retention via the change in TBE column height. Although short-term (1-month follow-up period) symptomatic improvement after pneumatic dilation generally was associated with reduced esophageal retention, a subset of patients with symptomatic improvement had persistent esophageal retention. 15 Further study showed that this symptomdiscordant esophageal retention was a strong predictor for therapeutic failure and need for re-intervention within 1 year. 3 Although baseline TBE studies were not uniformly available in the current study to all for a similar assessment, we did observe discordance between PRO and measures of esophageal retention at follow-up evaluation, supporting the use of objective esophageal function data, including TBE and manometry, in addition to a PRO in the outcome assessment in achalasia.
When applied to patients with ineffective esophageal motility, assessing dichotomous esophageal bolus clearance with intraluminal impedance aided characterization of the functional consequence of the peristaltic abnormalities. 6, 16 Moreover, there was a good correlation between bolus transit and retention on TBE in patients with achalasia after intervention. 17 Distinct from the qualitative assessment provided by the conventional impedance-manometry approach, the EII ratio provides a quantitative assessment of impaired bolus transit and associated bolus retention. [6] [7] [8] [9] In addition, the EII ratio can be used irrespective of the initial baseline impedance values, which is otherwise a limitation of HRIM assessment in patients with achalasia. Furthermore, the EII ratio can be calculated regardless of the integrity of peristalsis, which is fundamental for the calculation of other HRIM pressureflow metrics. 18 In this study, the EII shows a significant association with achalasia symptoms, which was not observed consistently using the dichotomized bolus transit assessment.
The present study represents an application of the EII ratio to achalasia. The EII ratio appeared to be a useful HRIM metric among patients with nonobstructive dysphagia because it shows the strongest correlation with dysphagia among various HRIM metrics among patients without a major esophageal motility disorder. 9 We recently reported that a novel HRIM measure of transesophagogastric junction flow, the bolus flow time (BFT), provided an improved evaluation of EGJ function related to clinical outcomes in achalasia over conventional manometric measures of EGJ pressure (including the integrated relaxation pressure, which was increased, ie, >15 mm Hg, in 19 of 70, 27% of the present cohort). 10 Although the BFT provides an evaluation of esophageal emptying, the EII ratio addresses the consequence of impaired esophageal emptying, specifically bolus retention. Although the EII ratio carried a stronger symptom association than the BFT among patients without major motility disorders, the sensitivity and specificity to detect a good PRO with the BFT (using a cut-off point of 0 seconds) among this achalasia cohort evaluated during follow-up evaluation after treatment was 78% and 77%, respectively. 9, 10 These are similar values to those observed with the EII ratio in this study. However, the agreement of the BFT and EII ratio among this cohort was only moderate (k ¼ 0.491).
Although both the TBE and EII ratio assess esophageal retention, TBE assesses retention of a larger volume over time while the EII ratio reflects the amount of esophageal retention associated with small-volume swallows. Furthermore, TBE provides important anatomic information. These differences may account for the low correlation between the 2 measures, but also may account for their beneficial complementary nature. Having both a favorable TBE column height and EII ratio provided an improved association with good PRO than either metric alone. This was not observed with the dichotomized measure of bolus transit. Although additional prospective studies are needed to validate the use of the EII ratio to aid management decisions, these results are promising.
Limitations of our study included the use of the Eckardt score, which is a nonvalidated, albeit commonly used, PRO with its own inherent limitations. We attempted to offset this limitation by also including a validated dysphagia chest pain PRO, the BEDQ. 12 Furthermore, although our aim was to assess metrics based on small-volume liquid swallows and liquid barium retention to generalized symptom scores, this does not completely address symptom generation in achalasia, which would require swallow-based perception assessment during the HRIM or TBE study, possibly including viscous or solid boluses. In addition, because calculation of the EII ratio requires use of both HRM with impedance and a customized MATLAB program, it is quite technical and not yet widely available, limiting the generalizability of this study to use in general practice. However, future integration of this metric into commercially available HRIM analysis software could expand its clinical use to potentially aid outcome evaluation in achalasia. Finally, although the association of clinical factors, such as achalasia subtype or treatment modality, with treatment outcome could be inferred from our results (as in Table 1 ), our study did not intend to assess these associations that are subject to selection and referral biases.
In conclusion, the goals of achalasia treatment are both to improve patient symptoms and reduce esophageal retention. Our evaluation of objective measures of esophageal retention shows the value of the EII ratio as an outcome assessment tool in achalasia, both independently and as a complementary measure to TBE column height. Although further prospective studies are necessary, use of novel HRIM metrics complemented by TBE may improve the outcome assessment of achalasia treatments.
